Inhibitor Therapeutics (INTI) Other Non-Current Assets (2013 - 2021)
Inhibitor Therapeutics (INTI) posted Other Non-Current Assets of $2,439 for Q3 2021, down 92.3% from $31,731 a year earlier and down 75.0% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Other Non-Current Assets (2013 - 2021) Analysis & Trends
At the end of FY2020, Inhibitor Therapeutics' Other Non-Current Assets came in at $24,408, down 54.5% from FY2019.
- Annual Other Non-Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -37.2% (FY2015 to FY2020).
- In prior years, Inhibitor Therapeutics' Other Non-Current Assets was $53,700 in FY2019 (-35.3%), $82,992 in FY2018 (-26.1%), $112,284 in FY2017 (-20.7%) and $141,576 in FY2016 (-43.4%).
- The Q3 2021 figure stands as the lowest quarterly Other Non-Current Assets in data going back to Q4 2013.
- On a year-over-year basis, Other Non-Current Assets has declined in each of the last 20 quarters, with an average decline of 56.2% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Non-Current Assets ran from 20.7% in Q4 2017 to 92.3% in Q3 2021.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $9,762 (Q2 2021), $17,085 (Q1 2021) and $24,408 (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 2,439.00 |
| Jun 30, 2021 | 9,762.00 |
| Mar 31, 2021 | 17,085.00 |
| Dec 31, 2020 | 24,408.00 |
| Sep 30, 2020 | 31,731.00 |
| Jun 30, 2020 | 39,054.00 |
| Mar 31, 2020 | 46,377.00 |
| Dec 31, 2019 | 53,700.00 |
| Sep 30, 2019 | 61,023.00 |
| Jun 30, 2019 | 68,346.00 |
| Mar 31, 2019 | 75,669.00 |
| Dec 31, 2018 | 82,992.00 |
| Sep 30, 2018 | 90,315.00 |
| Jun 30, 2018 | 97,638.00 |
| Mar 31, 2018 | 104,961.00 |
| Dec 31, 2017 | 112,284.00 |
| Sep 30, 2017 | 119,607.00 |
| Jun 30, 2017 | 126,930.00 |
| Mar 31, 2017 | 134,253.00 |
| Dec 31, 2016 | 141,576.00 |
API Access
Inhibitor Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();